Harmanjit Singh, Anjelli Wignakumar, Georgina J Williams, Shima Jamshidi, Daniel P Butler, Simon H Wood, Navid Jallali, Jonathan A Dunne
{"title":"荷兰前哨淋巴结黑色素瘤分期增加:仍有进一步改善的空间和需要。","authors":"Harmanjit Singh, Anjelli Wignakumar, Georgina J Williams, Shima Jamshidi, Daniel P Butler, Simon H Wood, Navid Jallali, Jonathan A Dunne","doi":"10.2217/mmt-2020-0018","DOIUrl":null,"url":null,"abstract":"Harmanjit Singh‡ ,1, Anjelli Wignakumar‡ ,1, Georgina J Williams2, Shima Jamshidi3, Daniel P Butler2, Simon H Wood2, Navid Jallali2 & Jonathan A Dunne*,2 1Imperial College School of Medicine, Kensington, London SW7 2DD, UK 2Department of Plastic Surgery, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Rd, Hammersmith, London W6 8RF, UK 3Department of Plastic Surgery, Royal Free London NHS Foundation Trust, Pond St, Hampstead, London NW3 2QG, UK *Author for correspondence: jonathan.dunne1@nhs.net ‡Joint first authors","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2020-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3d/29/mmt-08-52.PMC7849948.pdf","citationCount":"3","resultStr":"{\"title\":\"Increase of sentinel lymph node melanoma staging in The Netherlands: still room and need for further improvement.\",\"authors\":\"Harmanjit Singh, Anjelli Wignakumar, Georgina J Williams, Shima Jamshidi, Daniel P Butler, Simon H Wood, Navid Jallali, Jonathan A Dunne\",\"doi\":\"10.2217/mmt-2020-0018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Harmanjit Singh‡ ,1, Anjelli Wignakumar‡ ,1, Georgina J Williams2, Shima Jamshidi3, Daniel P Butler2, Simon H Wood2, Navid Jallali2 & Jonathan A Dunne*,2 1Imperial College School of Medicine, Kensington, London SW7 2DD, UK 2Department of Plastic Surgery, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Rd, Hammersmith, London W6 8RF, UK 3Department of Plastic Surgery, Royal Free London NHS Foundation Trust, Pond St, Hampstead, London NW3 2QG, UK *Author for correspondence: jonathan.dunne1@nhs.net ‡Joint first authors\",\"PeriodicalId\":44562,\"journal\":{\"name\":\"Melanoma Management\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2020-12-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3d/29/mmt-08-52.PMC7849948.pdf\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Melanoma Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/mmt-2020-0018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/mmt-2020-0018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Increase of sentinel lymph node melanoma staging in The Netherlands: still room and need for further improvement.
Harmanjit Singh‡ ,1, Anjelli Wignakumar‡ ,1, Georgina J Williams2, Shima Jamshidi3, Daniel P Butler2, Simon H Wood2, Navid Jallali2 & Jonathan A Dunne*,2 1Imperial College School of Medicine, Kensington, London SW7 2DD, UK 2Department of Plastic Surgery, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Rd, Hammersmith, London W6 8RF, UK 3Department of Plastic Surgery, Royal Free London NHS Foundation Trust, Pond St, Hampstead, London NW3 2QG, UK *Author for correspondence: jonathan.dunne1@nhs.net ‡Joint first authors
期刊介绍：
Skin cancer is on the rise. According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year. While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably. Therefore, research into combating advanced-stage melanoma is a high priority. New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing. Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
